Profile | GDS2987 / GI_20070338-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 95.4 | 76 |
GSM215244 | HMVEC_vehicle_rep2 | 107 | 76 |
GSM215253 | HMVEC_vehicle_rep3 | 116.3 | 78 |
GSM215254 | HMVEC_atorvastatin_rep1 | 119.5 | 77 |
GSM215282 | HMVEC_atorvastatin_rep3 | 118.3 | 77 |
GSM215344 | HMVEC_atorvastatin_rep2 | 129.1 | 78 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 145.2 | 79 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 116.2 | 77 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 113.2 | 76 |
GSM215294 | HMVEC_SLx2119_rep1 | 78.4 | 75 |
GSM215295 | HMVEC_SLx2119_rep2 | 93.1 | 74 |
GSM215296 | HMVEC_SLx2119_rep3 | 74.8 | 71 |
GSM215297 | PASMC_vehicle_rep1 | 3 | 5 |
GSM215298 | PASMC_vehicle_rep2 | 13.5 | 21 |
GSM215310 | PASMC_vehicle_rep3 | 49.9 | 61 |
GSM215311 | PASMC_atorvastatin_rep1 | 2.3 | 4 |
GSM215312 | PASMC_atorvastatin_rep2 | 33.9 | 47 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 11.3 | 22 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 14.5 | 25 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 1.2 | 3 |
GSM215331 | Fibroblasts_vehicle_rep2 | 24.2 | 54 |
GSM215332 | Fibroblasts_vehicle_rep3 | 15.2 | 45 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 8.3 | 22 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 8.7 | 25 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 15.4 | 36 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 13.3 | 40 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 28.7 | 62 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 6.3 | 18 |
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 12.6 | 34 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 19.5 | 44 |